Dexamethasone and the risk for adrenal suppression in multiple myeloma

Leukemia

Volumn 23, Issue 5, 2009, Pages 1009-1011

  Ng, A C ^a   Kumar, S K ^a   Russell, S J ^a   Rajkumar, S V ^a   Drake, M T ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; LENALIDOMIDE;

ADRENAL INSUFFICIENCY; ADRENAL SUPPRESSION; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; INFECTION; LOW DRUG DOSE; LUNG EMBOLISM; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK FACTOR; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 67349259582     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.373     Document Type: Article

References (7)

1. Rajkumar SV, Jacobus S, Callander N, Fonseca R, Vesole D, Williams M et al. A randomized trial of lenalidomide plus high-dose dexamethasone (RD) versus lenalidomide plus low-dose dexamethasone (Rd) in newly diagnosed multiple myeloma (E4A03): A trial coordinated by the Eastern Cooperative Oncology Group. Blood (ASH Annual Meeting Abstracts) 2006; 108: 799.
2. Axelrod L. Glucocorticoid therapy. Medicine (Baltimore) 1976; 55: 39-65.
3. Krasner AS. Glucocorticoid-induced adrenal insufficiency. JAMA 1999; 282: 671-676.
4. Schlaghecke R, Kornely E, Santen RT, Ridderskamp P. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med 1992; 326: 226-230.
5. Grinspoon SK, Biller BM. Clinical review 62: Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 1994; 79: 923-931.
6. Nieman LK. Dynamic evaluation of adrenal hypofunction. J Endocrinol Invest 2003; 26 (7 Suppl): 74-82.
7. Hagg E, Asplund K, Lithner F. Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency. Clin Endocrinol (Oxf) 1987; 26: 221-226.